Literature DB >> 11351138

Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks.

R Swainson1, J R Hodges, C J Galton, J Semple, A Michael, B D Dunn, J L Iddon, T W Robbins, B J Sahakian.   

Abstract

The development of novel treatments for Alzheimer's disease (AD), aimed at ameliorating symptoms and modifying disease processes, increases the need for early diagnosis. Neuropsychological deficits such as poor episodic memory are a consistent feature of early-in-the-course AD, but they overlap with the cognitive impairments in other disorders such as depression, making differential diagnosis difficult. Computerised and traditional tests of memory, attention and executive function were given to four subject groups: mild AD (n = 26); questionable dementia (QD; n = 43); major depression (n = 37) and healthy controls (n = 39). A visuo-spatial associative learning test accurately distinguished AD from depressed/control subjects and revealed an apparent sub-group of QD patients who performed like AD patients. QD patients' performance correlated with the degree of subsequent global cognitive decline. Elements of contextual and cued recall may account for the task's sensitivity and specificity for AD. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11351138     DOI: 10.1159/000051269

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  84 in total

1.  Neuropsychological components of intellectual disability: the contributions of immediate, working, and associative memory.

Authors:  Jamie O Edgin; Bruce F Pennington; Carolyn B Mervis
Journal:  J Intellect Disabil Res       Date:  2010-05

2.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

4.  The effect of pacemaker mode on cognitive function.

Authors:  G M Gribbin; P Gallagher; A H Young; J M McComb; P McCue; W D Toff; R S Bexton; J M Bland; R A Kenny
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

Review 5.  Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience.

Authors:  Anand Kumar; Olusola Ajilore; Vladimir Kepe; Jorge R Barrio; Gary Small
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

Review 6.  DHA may prevent age-related dementia.

Authors:  Greg M Cole; Sally A Frautschy
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

7.  Ketamine impairs multiple cognitive domains in rhesus monkeys.

Authors:  Michael A Taffe; Sophia A Davis; Tannia Gutierrez; Lisa H Gold
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

Review 8.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

9.  Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys.

Authors:  Stefani N Von Huben; Sophia A Davis; Christopher C Lay; Simon N Katner; Rebecca D Crean; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2006-03-15       Impact factor: 4.530

10.  Hyperthermia impairs short-term memory and peripheral motor drive transmission.

Authors:  S Racinais; N Gaoua; J Grantham
Journal:  J Physiol       Date:  2008-08-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.